Morehouse School of Medicine

The HPOs will receive $13.8 million to enroll people interested in the All of Us program, gather participant health information, and help retain participants.

The oncology data warehouse started by the Moffitt Cancer Center and Ohio State University Comprehensive Cancer Center now has nine members.

This story has been updated from a version published Aug. 15 to reflect the fact that Iverson Genetics has not yet selected a testing partner for the WARFARIN trial.

Morehouse School of Medicine will use the NIH funding and work with several partners to start a minority database focused first on hypertension and personalized medicine.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.